Journal article

Is it time for everolimus-based combination in castration-resistant prostate cancer?

G Roviello, A Ravelli, S Barni, F Petrelli, A Bottini, SB Fox, D Generali

Future Oncology | FUTURE MEDICINE LTD | Published : 2016

DOI: 10.2217/fon-2016-0136

University of Melbourne Researchers

Citation metrics

1Scopus
1Web of Science
1Dimensions

Keywords

Cells
Mtor Pathway
Trial
32 Biomedical and Clinical Sciences
Ar-V7
Receptor Splice Variants
Abiraterone
Testosterone
Prostate Cancer
Androgen Receptor
Pathway
Life Sciences & Biomedicine
3211 Oncology and Carcinogenesis
Science & Technology
Oncology